Several members of the U.S. House of Representatives, including Rep. Colin Allred, Rep. Nicole Malliotakis, and Rep. Jason Smith, are addressing the issue of drug shortages and the reliance on foreign nations for the pharmaceutical supply chain. The bipartisan Substance Use Disorder Workforce Act, introduced by Rep. Allred, aims to increase the number of physicians equipped to combat the overdose epidemic. The Ways and Means GOP committee is exploring solutions to end medicine shortages, reduce costs for prescription drugs, and bring the pharmaceutical supply chain back to the U.S. Concerns have been raised about the heavy reliance on foreign nations such as China for the drug supply chain, with a focus on the potential health and safety risks and the impact on rural communities' access to medications. Legislation has been introduced to prepare medical students for the unique health needs of rural populations and strengthen the healthcare workforce. The issue of drug shortages affecting patient and provider access to medications, as well as the delay in research, development, testing, and approval of new treatments, has been highlighted in recent discussions and hearings.
I spoke with @jrgralow in the @WaysMeansCmte about how we can address the drug shortages our families are facing. I'll continue to support investments that improve our supply chain, like the cutting-edge research at @UConnPharmacy to modernize prescription drug manufacturing. https://t.co/olKaOha6Pm
In today's @WaysandMeansGOP hearing I discussed the risks of relying on medical manufacturing in China and the imperative need to secure access to lifesaving drugs, especially for patients in rural areas. All Kansans deserve the same access to high quality care and treatments. https://t.co/NHonw1lBdw
In rural communities, timely access to life-saving medications is essential to safeguarding patient health. At our @WaysandMeansGOP hearing, I discussed the challenges rural communities face to access drugs and the need to reduce our reliance on foreign drug manufacturers. https://t.co/0DcYbqeEUN
All patients deserve quality health care no matter where they live. I introduced the Community TEAMS Act with @RepAnnieKuster that will allow medical students to train in rural areas. They are the future of health care in underserved areas of the U.S.https://t.co/086cFl3GFm
We held an important hearing today on chronic drug shortages. We’ve made progress fixing our supply chains but if we’re running out of cancer drugs because we rely too much on China we have work to do. https://t.co/SBQid2mZau
We held an important hearing today on chronic drug shortages. We’ve made progress fixing our supply chains but if we’re running out cancer drugs because we rely too much on China we have work to do. https://t.co/qwbSYRUsMP
Rural communities in NH and beyond are in desperate need of doctors and health care workers. Today, I was proud to introduce legislation to prepare medical students for the unique health needs of rural populations and strengthen our health care workforce. https://t.co/vGzWkMevbg
Drug shortages not only affect patient and provider access to today's medications. Research and development, testing, and approval of new treatments can be impaired as well and those medications delayed or kept from the market. @repkevinhern https://t.co/96J97VTyP2
Relying on foreign sources can compromise the health and safety of medications. As @RepBradWenstrup points out, importing drugs opens them up to potential contamination that can further threaten the health of Americans. https://t.co/ZoO18qquFW
In drug manufacturing , China seeks to dominate by, in part, engaging in predatory manipulations of the market. America should not be relying on China to faithfully maintain the global drug supply chain. @RepLaHood https://t.co/GZqXNxEhOy
Investing in drug stocks to have medications on hand can place a large financial burden on providers, especially rural providers. This can impact the accessibility to care in rural areas and cause costs to rise. @RepAdrianSmith https://t.co/TLZnmLHsys
The COVID-19 pandemic showed us that America is far too reliant on foreign nations for our critical supply chain needs, especially when it comes to life-saving drugs. However, the United States' drug supply chain is still heavily reliant on foreign nations such as China and… https://t.co/dd0XAKXfP0
TUNE IN at 10:00 AM as @WaysandMeansGOP explores solutions to END medicine shortages in the United States, bring our pharmaceutical supply chain home & reduce costs for prescription drugs. ⬇️ https://t.co/SKZGLuHlg6
Our communities must have the necessary tools and trained workers to address substance use disorders. That's why I cosponsored the bipartisan Substance Use Disorder Workforce Act to increase the number of physicians equipped to combat the overdose epidemic.